In clear cell renal cell carcinoma (ccRCC), comprehensive analysis of m6A-seq and mRNA-seq analysis identified the glutamine transporter SLC1A5 as an FTO target, and the FTO-SLC1A5 axis is crucial for the metabolic reprogramming and survival of ccRCC cells (Xiao et al., 2020). This evidence concerns the gene FTO and nonpapillary renal cell carcinoma.